Difference between revisions of "Hepatitis B"

Jump to navigation Jump to search
114 bytes added ,  17:42, 25 June 2016
Line 4: Line 4:
*May lead to [[hepatocellular carcinoma]] without [[cirrhosis]].
*May lead to [[hepatocellular carcinoma]] without [[cirrhosis]].
*High prevalence.
*High prevalence.
*Diagnosis is by serology.
*Diagnosis is by serology - details of serologic testing are in the ''[[Medical_liver_disease#Hepatitis_B|medical liver disease article]]''.
*A vaccination is available and done routinely in a many jurisdictions.<ref>{{Cite journal  | last1 = Leuridan | first1 = E. | last2 = Van Damme | first2 = P. | title = Hepatitis B and the need for a booster dose. | journal = Clin Infect Dis | volume = 53 | issue = 1 | pages = 68-75 | month = Jul | year = 2011 | doi = 10.1093/cid/cir270 | PMID = 21653306 }}</ref>  
*A vaccination is available and done routinely in a many jurisdictions.<ref>{{Cite journal  | last1 = Leuridan | first1 = E. | last2 = Van Damme | first2 = P. | title = Hepatitis B and the need for a booster dose. | journal = Clin Infect Dis | volume = 53 | issue = 1 | pages = 68-75 | month = Jul | year = 2011 | doi = 10.1093/cid/cir270 | PMID = 21653306 }}</ref>  


48,836

edits

Navigation menu